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Objectives: To examine the precocity-longevity (P-L) effect in North American pro-
fessional basketball players who debuted between 1946 and 1979, and to determine 
whether playing position and decade of play influenced the relationship between age of 
career achievements and life span.
Methods: A total of 1852 players were evaluated from a recognized sports archive 
(i.e., http://sports-reference.com), which provided information on date of birth, death, 
and career debut, playing position, and indicators of achievement (i.e., All-Star team 
and/or All-League team selection). Athletes were categorized as above or below the 
median age of professional debut and median age of selection to first All-Star team and/
or All-League team. Analyses of deceased players (n = 598) were comprised of bivariate 
correlations between age of achievement (age of debut, age of first All-Star game, and 
age of first All-League team selection) and age of death, and t-tests to compare the 
average age of death of early and late achievers (p < 0.05). Survival analyses, using the 
entire sample (living and deceased players), compared the life spans between those 
who debuted above and below the median age of achievement for each indicator of 
achievement.
results: Only the correlation between age of professional debut and age of death 
(r = 0.33, p < 0.001), age of first All-Star game and age of death (r = 0.29, p < 0.05), and 
the t-test comparing the average death age of early (66.4 years) and later (69.3 years) 
debut age groups (p = 0.01) reached statistical significance. However, survival analyses 
demonstrated a trend for lower risk of death for early achievers, with one exception (i.e., 
age of debut); this trend was not statistically significant.
conclusion: Results did not support the P-L hypothesis, suggesting that sample 
characteristics (i.e., physical fitness of high performance athletes), and measurement 
methodologies, may influence support for the proposed hypothesis in sport. However, 
future research would benefit form larger sample sizes and cause of death data.
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inTrODUcTiOn
The precocity-longevity (P-L) hypothesis asserts that those 
who experience noteworthy high achievements earlier in life 
have a shorter life span than those who attain similar notable 
career milestones later in life. This hypothesis was first formally 
described by McCann (1) in a study of high achievers in politics 
(presidents and prime ministers), law, entertainment, creative 
pursuits, and academia. Results suggested that the younger a 
person is when they achieve a notable peak in achievement 
(or a landmark contribution) the younger they tend to die. For 
example, Nobel Peace prize recipients who received the award 
above the median age of 64.8 years lived 13.5 years longer than 
those who received the prize before this age [p < 0.01; Ref. (1)].
Two mechanisms have been at the forefront of discussion 
(and have existed from the hypothesis’ inception): stress and 
personality type. First, McCann (1) suggested that the stress, 
challenges, and obligations that accompany precocious achieve-
ment have the potential to be a catalyst for poor health. McCann 
(1) further highlighted that the ascension to career success may 
play an important role: “the stresses that accompany a rapid 
drive to achievement peaks may eventually contribute to a 
shorter life” (p. 1430). Research does support that stressful 
experiences predispose humans to disease, and ultimately 
premature death [e.g., Taylor (2)], and that repetitive stress 
may activate physiological responses that cause stress-related 
diseases to emerge (3).
Personality type, the more stable and ingrained form of 
individual character, is the other proposed mechanism of the P-L 
effect (1). Type A personalities tend to be competitive, self-critical, 
ambitious, goal-oriented, impatient, and aggressive; alternatively, 
Type B personalities are relaxed and non-competitive (4). The 
seminal study by cardiologists Friedman and Rosenman (5) found 
that Type A personalities have a higher risk of heart disease and 
high blood pressure relative to Type B personalities. However, 
contemporary research suggests a more complicated relation-
ship between components of Type A personality (i.e., hostility 
and anger) and disease [e.g., Myrtek (6)]. Nevertheless, previous 
studies on the P-L relationship may have examined samples that 
likely fall in some components of the Type A personality category, 
such as professional baseball players (7) and eminent persons 
such as presidents, prime ministers, and monarchs (1), making 
personality type a potential mechanism.
Although etiological studies of the P-L effect will be impor-
tant, it has been suggested that a more immediate objective 
should be to determine the existence and generalizability of 
the phenomenon (8). To date, however, only a few studies have 
investigated the existence and generalizability of the P-L effect 
in the athletic disciplines. Abel and Kruger’s (7) investigation 
of deceased Major League Baseball (MLB) players noted that 
when precocity was defined as age in which athletes debut 
professionally, there was a significant relationship with life span 
longevity; for every year a player debuted before the average age 
of 23.6 years (SD = 2.3), their life span decreased by 0.24 years. 
Further, correlations between debut age and longevity were 
higher in Hall of Fame inductees relative to non-inductees (0.48 
vs. 0.09, respectively), which further supported the proposition 
that precocious achievement may have negative effects on 
longevity. Alternatively, a recent analysis by Lemez et al. (9) on 
Canadian professional ice hockey players did not demonstrate 
a clear P-L effect. The authors speculated that the positive rela-
tionship between cardiovascular fitness and reduced all-cause 
mortality may explain the lack of an effect among ice hockey 
players compared to baseball and non-athletic eminent achiev-
ers. However, with only two studies to date on high achieving 
athlete populations, there is a clear need to explore the P-L effect 
in other athlete samples.
In addition to there being a limited number of studies on high 
performing athletic populations, there are also methodological 
challenges inherent to research on the P-L effect. First, there 
are some epidemiological and methodological influences that 
may affect the P-L effect: life expectancy and selection artifacts. 
The life expectancy artifact describes the potential that younger 
death age among high achievers may result from the fact that 
younger age is associated with shorter life expectancy (1). There 
is also the possibility that early death (and hence early achieve-
ment) simply permits a person to enter a study sample. This 
“selection artifact” (10) means that the absence of still-living 
early achievers may skew effects in favor of a P-L effect. Both 
of these artifacts describe the inherent potential for bias when 
studying a sample of only deceased eminent achievers and may 
increase the likelihood of Type I error (i.e., identifying a P-L 
effect when one does not exist).
There may also be challenges to studying the P-L effect as a 
result of how “precocity of achievement” is operationalized. Both 
Abel and Kruger (7) and Lemez et  al. (9) defined precocious 
achievement in athlete samples as the age at which athletes entered 
professional sport. However, using age of professional sport debut 
as a measure of achievement may be impacted by the fact that the 
age range for professional sport debut is typically quite narrow 
(7). If this range is sufficiently narrow, it would be difficult to find 
clear support for the P-L effect as the age difference between “early 
achiever” and “late achiever” would be quite small. Lemez et al. 
(9) suggested that one way to circumvent these issues would be to 
use an alternate marker of accomplishment more independent of 
age and more indicative of exceptional achievement, such as age 
at first participation in an “All-Star” game.
Taken together, there is a need to study the generalizability 
of the P-L effect in different domains (e.g., sport vs. non-sport), 
and there is a need to start reconciling the methodological chal-
lenges inherent to studying this phenomenon. Based on the two 
studies of the P-L effect among eminent athletes, this study has 
two aims: (1) to explore the generalizability of the P-L effect 
among high achievers in a sample of athletes not previously 
studied (i.e., North American professional basketball players) 
and (2) to address some of the methodological challenges that 
are important to consider in this area of research. To that end, 
the current study aimed to explore the P-L effect using diverse 
approaches. First, we replicated previous methodologies for 
analyzing the effect using a sample of only deceased athletes in 
order to compare this sample to previous research. Second, the 
unique approach of analyzing an inclusive sample of deceased 
and living athletes allowed more ecologically valid analyses to 
be performed. Based on previous P-L research on athlete and 
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non-athlete samples, we hypothesized that athletes who had 
younger ages of notable achievement would have shorter life 
spans than those who had notable achievement at older ages.
MaTerials anD MeThODs
sample and Variables
This study did not involve any human participants or animals and 
therefore adhered to recognized ethical standards and national/
international laws (11). Data were collected for all players who 
had played professional basketball from 1946 to 2012 (N = 4015) 
from a recognized sports archive of aggregated publically available 
athlete records (i.e., http://sports-reference.com). During this 
period two professional leagues existed, the National Basketball 
Association (NBA) and the American Basketball Association 
(ABA). A random sample of the data (10%) was also cross 
referenced with an official NBA encyclopedia (12) and showed 
complete consistency. We censored all players who debuted from 
1980 to 2012 because the majority (98.4%) of that cohort was still 
living. This resulted in a final sample size of 1852. Of this overall 
sample, 598 were deceased.
For each player, date of birth, career milestones (i.e., first 
year of professional debut, last year of play, date of first All-
Star game, date of first All-League selection), playing position 
(i.e., Guard, Center, or Forward), and date of death were col-
lected. The All-Star game is an annual mid-season exhibition 
game where 12 players from each conference (i.e., Eastern and 
Western) who are playing at a notably high-level are selected by 
fans (starters) and coaches (reserves). Similarly, an All-League 
selection honors the best players following a season to two teams 
from 1946 to 1988 (N = 10), which are selected by a panel of 
sportswriters and broadcasters throughout Canada and the 
United States [e.g., Ref. (13)]. From the above data, a number of 
additional variables were derived for the current study, includ-
ing (i) length of playing career (in seasons played), (ii) age at 
the start of playing career, (iii) age at first All-Star game, (iv) 
age at first All-League team selection, (v) age at time of death 
(in years), and (vi) age as of January 2013 (days) for living and 
former athletes. Although age-related variables were computed 
and analyzed in “days,” results are presented in years for ease of 
understanding. Athletes were also coded as either deceased or 
living for the purpose of analyses.
Precocity of achievement was defined in three different 
ways. First, we replicated Abel and Kruger’s (7) definition 
of achievement as “age upon entering professional sport.” In 
addition, in order to have a measure of achievement more inde-
pendent of age, and more indicative of eminent achievement 
in this population, two other indicators of achievement were 
included, “age at first All-Star game” and “age at first All-League 
selection.” For each indicator of achievement, variables were 
computed using a player’s first notable achievement. This was 
necessary because the ABA only existed from 1967 to 1976, and 
therefore some players debuted in the ABA and transferred to 
the NBA (and vice versa). For example, if a player debuted or 
was nominated to an All-Star game in the ABA then later trans-
ferred to the NBA, the achievement values were derived from 
their ABA. Consistent with previous research, we explored 
career precocity by coding athletes as debuting either below 
or above the median “age of achievement” for each indicator of 
achievement. The median ages of achievement were calculated 
separately for each decade of debut, since these values fluctu-
ate (this was particularly important for debut age, which has 
declined in more recent decades).
analyses – Part 1 (Deceased sample)
The purpose of our first set of analyses was to replicate the 
methods of previous studies in an unstudied population (i.e., 
professional basketball players) and with additional indicators 
of achievement. Specifically, these analyses used a subsample of 
only deceased players who had debuted prior to 1980 (n = 598), 
similar to previous research on eminent athlete and non-athlete 
samples (1, 7). As such, all coding of the achievement measures in 
this portion of the analyses were based on the values (i.e., median 
ages of achievement) obtained from the deceased subsample of 
NBA players.
We described the study sample by calculating the median age 
of death, the sample composition according to playing position 
(Center, Forward, Guard), and the proportion of deceased ath-
letes who had participated in an All-Star game, and who had been 
selected to an All-League team.
In accordance with previous research [see McCann (1)], 
each of the three measures of achievement were correlated, and 
partially correlated (controlling for decade of debut), with age 
at death (p < 0.05). Similarly, t-tests compared the mean ages of 
death for those who were above and below the median ages of 
achievement for each of the three measures of achievement.
Two final analyses were included in Part 1. We also categorized 
athletes as above (later death) or below (early death) the median 
age of death (where each median death age was decade specific) 
and categorized athletes as either “eminent” or “not eminent” 
based on whether or not they had been selected as an All-Star 
or to an All-League team (respectively). Using these categoriza-
tions, two 2 × 2 chi-squares were run with a p < 0.05 significance 
criteria: All-Star eminence (yes/no) × death age (early/later); All-
League team eminence (yes/no) × death age (early/later). Similar 
to Abel and Kruger’s (7) distinction between Hall of Fame and 
non-Hall of Fame athletes, these analyses sought to distinguish 
any potential differences in longevity associated with degree of 
eminence.
analyses – Part 2 (alive or Deceased 
sample)
The second set of analyses for this study aimed to address the 
possibility that a P-L effect observed in a sample comprised of 
deceased eminent achievers may result from still-living eminent 
achievers not having entered the study sample [i.e., the selection 
artifact: Simonton (10)]. Therefore, these analyses used a sample 
of deceased and still-living players who had debuted prior to 
1980 (n =  1852) with the aim of testing whether or not those 
with earlier death age are in fact more precocious achievers than 
still-living athletes. As with the first portion of analyses, achieve-
ment was defined as (i) age of professional debut, (ii) age at first 
All-Star game, and (iii) age at first All-League team selection. 
However, when coding athletes as above or below the median age 
TaBle 2 | T-test comparisons of the mean death age between earlier and later achievers.
Test Measure of achievement Mean death age (years) t (df) p value
T-tests above vs. below median achievement agea earlier achiever M (sD) later achiever M (sD)
Age of pro debut (n = 598) M = 66.4 (±15.2) M = 69.3 (±14.3) t (596) = 2.34 0.02
Age first All-Star game nomination (n = 69) M = 62.2 (±16.7) M = 67.7 (±9.6) t (67) = 1.65 0.10
Age first All-League team nomination (n = 38) M = 63.1 (±17.4) M = 69.1 (±10.1) t (36) = 1.27 0.21
aAge of median achievement was calculated for each decade, and median splits were respective to athletes’ decade of entry to professional sport; M, mean. All of the above 
analyses were repeated using restricted inclusion criteria that ensured no athlete had died before all the individuals in the sample had accomplished their measure of career 
achievement.
TaBle 1 | Bivariate and partial correlations between age of achievement measures and age of death.
Test correlations Measure of achievement (age) Death age (r) p value Death age (r)a p value
Age pro debut (n = 598) 0.33 <0.001 0.11 <0.01
Age first All-Star game nomination (n = 69) 0.29 <0.05 0.22 0.07
Age first All-League team nomination (n = 38) 0.10 0.54 0.27 0.10
aPartial correlation controlling for decade of entry to professional basketball. All of the above analyses were repeated using restricted inclusion criteria that ensured no athlete had 
died before all the individuals in the sample had accomplished their measure of career achievement.
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of achievement (for each indicator of achievement), the values 
of the entire sample (living and deceased) of athletes were used 
for these analyses (with median achievement values calculated 
separately for each decade of play and pertinent league).
We described the study sample by providing the proportions of 
each playing position (Center, Forward, Guard), and the propor-
tion of the sample who had participated in an All-Star game, and 
who had been selected to an All-League team. We also describe 
the sample by listing the median age (in days) of achievement 
for the three indicators of achievement (stratified by decade) 
separately for deceased and still-living players.
Three Kaplan–Meier (KM) analyses were used to explore the 
univariate patterns and median survival between each career 
achievement (i.e., precocity) indicator and longevity (p < 0.05), 
and to show censoring. Cox proportional hazards regression was 
performed to assess the influence of career precocity on life span, 
while adjusting for potential confounders (i.e., playing position 
and decade of career debut). Hazard ratios (HR) and 95% confi-
dence intervals (95% CI) were used to estimate the relationship 
between precocity and longevity, after adjusting for covariates.
resUlTs – ParT 1 (DeceaseD saMPle)
The median age of death among the deceased players was 
70.3 years (SD ± 14.4 years). Overall, the majority of this sample 
was comprised of Guards (42.4%) and Forwards (42.5%), while 
Centers constituted only 15% of the sample. The majority of ath-
letes participated exclusively in the NBA (87.9%), while smaller 
proportions played exclusively in the ABA (7.4%) or played in 
both leagues (4.7%). Of the 598 deceased athletes, 11.5% had 
participated in an All-Star game, and 6.3% had been selected to 
an All-League team.
Table 1 presents the correlations between each of the achieve-
ment measures and age of death, as well as the results of the 
independent t-tests. Both age of professional debut and age of 
first All-Star game demonstrated statistically significant positive 
correlations with age of death. The relationship between age of 
professional debut and age of death was a medium size correla-
tion (r =  0.33) but decreased to a small correlation (r =  0.11) 
when decade of professional debut was adjusted for. The correla-
tion between age of first All-Star game and age of death was also 
medium-sized (r = 0.29), but this correlation was not statistically 
significant when decade of debut was adjusted for. Age at first 
All-League selection was not significantly correlated with age of 
death (regardless of whether decade of debut was adjusted for). 
T-tests were used to compare the average age of death between 
earlier and later achievers (see Table  2). Although there was a 
trend for early achievers to have a younger mean age of death for 
each of the indicators of achievement, the difference in death age 
was only statistically significant between those with earlier and 
later ages of professional debut (p = 0.01).
Neither the chi-square test for All-Star eminence (yes/
no) × death age [above vs. below median; χ2(1) = 0.13, p = 0.72] 
nor the chi-square test for All-League team eminence (yes/
no) × death age [above vs. below median; χ2(1) = 1.07, p = 0.30] 
provided any evidence for the P-L hypothesis.
resUlTs – ParT 2 (aliVe 
Or DeceaseD saMPle)
Of the 1852 players alive or deceased, the majority of the sample 
was comprised of Guards (42.4%) and Forwards (42.5%), while 
Centers constituted 15.1% of the sample. The majority of athletes 
participated exclusively in the NBA (73.4%), while smaller 
proportions played exclusively in the ABA (15.5%) or played in 
both leagues (11.1%). Overall, 14.7% had participated in an All-
Star game, and 6.7% had been selected to an All-League team. 
Descriptive comparisons of median age of achievement between 
living and deceased players revealed that living athletes had 
younger median ages of achievement on all Age of Professional 
Debut comparisons, and 5 out of 11 comparisons for Age at first 
All-Star and All-League team selection (see Figure 1).
FigUre 1 | Median age of achievement for alive and deceased nBa/aBa athletes, for debut age, all-league nomination, and all-star nomination.
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age of Professional Debut
The median life span for early achievers was higher than it was 
for late achievers (82.6 vs. 81.0 years), although this trend was 
not statistically significant [χ2(1, N = 1852) = 3.31, p = 0.07]. In 
a subsequent Cox regression, which adjusted for playing posi-
tion and decade of playing debut (see Table 3), career precocity 
was associated with a lower risk of death (HR: 0.84, 95% CI: 
0.71–0.98). No main effects were observed for decade of debut. 
However, compared to Guards, Forwards had a higher risk of 
death (HR: 1.21, 95% CI: 1.02–1.45), but no difference in risk of 
death among Centers. No two-way interactions were observed.
age at First all-star game
Although the median life span for early achievers was higher than 
it was for late achievers (84.1 vs. 80.7 years) in the current sample, 
this trend was not statistically significant [χ2(1, N = 271) = 0.05, 
p = 0.83]. In a subsequent Cox regression (see Table 3), which 
adjusted for playing position and decade of playing debut, career 
precocity was not independently associated with a lower risk of 
death. Moreover, no main effects were observed for decade of 
debut or playing position, and no interactions were observed.
age at First all-league Team selection
The median life span for early achievers was lower than it was 
for later achievers (82.4 vs. 84.1 years), although this trend was 
not statistically significant [χ2(1, N =  119) =  0.10, p =  0.75]. 
When decade of debut and playing position were adjusted for 
in a Cox regression (see Table 3), mortality risk did not differ 
between early and later achievers. No main effects were observed 
for decade of debut or playing position, and no interactions were 
observed.
DiscUssiOn
This study examined the relationship between precocity of 
achievement and longevity in elite professional basketball play-
ers. Previous work by McCann (1) and Abel and Kruger (7) 
observed that earlier achievement is associated with a shorter 
life span across different domains, including sport. However, the 
current results present a complicated picture of the P-L effect. 
Our interpretation is that overall the results do not support the 
P-L hypothesis.
First, the only statistically significant correlation and t-test 
were for the age of debut indicator of achievement. None of the 
Part 1 analyses on the age at first All-Star game and age at first All-
League selection reached statistical significance, although that 
may have resulted from lack of statistical power. The results of the 
chi-square tests for these two indicators of achievement also did 
not support the P-L hypothesis. However, given the small sample 
sizes in these analyses, there is the need to weigh the results of the 
first series of analyses against the results of Part 2.
The second series of analyses aimed to expand on the methods 
used in the majority of P-L research. It had previously been sug-
gested that younger death age among high achievers results from 
lower life expectancies associated with younger age (2) and that 
early death may simply permit a person to enter a study sample 
[i.e., the selection artifact: Simonton (10)]. The inclusion of still 
living and deceased athletes and the subsequent results of the 
survival analyses (Part 2) suggest that the concerns related to the 
above artifacts are well founded in the current population of high 
achievers. Not only did the results of the survival analyses not 
support the P-L hypothesis, the trends for the three indicators 
of eminent achievement were opposite to those in Part 1 and 
suggest a lower risk of death for precocious achievers. Although 
only the age of debut achievement indicator reached statistical 
significance, the other two indicators of achievement has similar 
effect sizes and may have been significant with larger sample sizes. 
There is of course a notable limitation to using survival analyses in 
instances where the exposure event (age of achievement) is itself a 
potential confounder of the outcome, which cannot be controlled 
for. In this case, it is not possible to control for the fact that pre-
cocious achievers are followed for a greater period of time than 
late achievers. The results of the current study should be weighed 
against such limitations [see Hanley and Foster (14)]. However, in 
TaBle 3 | hazard ratios for age of achievement, decade of debut, and playing position from cox regressions for age of debut, age of first all-star game, 
and age of first all-league team indicators of achievement.
Mortality risk
Measure of achievement Variables hradjusted 95% ci
Age of debut Age of achievement Early achievement 0.84 0.71–0.98
Late achievement – –
Decade of debut 1940s 1.01 0.81–1.51
1950s 0.95 0.69–1.33
1960s 0.87 0.63–1.20
1970s – –
Playing position Centers 1.20 0.94–1.52
Forwards 1.21 1.02–1.45
Guards – –
Age at first All-Star game Age of achievement Early achievement 0.82 0.54–1.44
Late achievement – –
Decade of debut 1940s 0.96 0.36–2.55
1950s 1.14 0.45–2.85
1960s 0.81 0.34–1.91
1970s – –
Playing position Centers 1.40 0.71–2.75
Forwards 1.64 0.95–2.83
Guards – –
Age at first All-League team Age of achievement Early achievement 0.80 0.40–1.61
Late achievement – –
Decade of debut 1940s 0.68 0.21–2.19
1950s 0.57 0.18–1.87
1960s 0.55 0.17–1.74
1970s – –
Playing position Centers 1.29 0.50–3.34
Forwards 1.38 0.66–2.88
Guards – –
HR, hazard ratio; CI, confidence interval; bold font, statistically significant HR.
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light of the notable limitations to the methods presented in Part 
1, we argue that survival analyses perhaps represents the lesser of 
two evils, and that for the time being a triangulation of multiple 
methods, which includes deceased-only and still-living athletes, 
may be prudent. It may be worth repeating; however, that one of 
the biases identified earlier is that precocious achievement and 
younger age is associated with greater risk of mortality (1, 2). 
As such, if the limitations inherent to survival analyses biased 
our findings, they theoretically should have reflected biased sup-
port for the P-L hypothesis. However, the results of the survival 
analyses do not conclusively support the P-L effect. We believe 
that these trends stem from the differences in age of achievement 
between living and deceased athletes.
The discrepancy between the trends observed in Part 1 and Part 
2 appear to be related to the different median age of achievements 
between still-living and deceased athletes (Figure 1). Descriptive 
trends suggest that in many cases the median achievement 
age of deceased athletes does not accurately reflect the median 
achievement age for the overall population of athletes. In some 
cases, it appears that the median age of achievement of the still-
living athletes is actually younger than that of the deceased-only 
subsample, especially with regard to the “age of debut” measure 
of achievement. These descriptive differences in median age of 
achievement suggest there is a P-L effect in the current sample, 
but unlike previous research, precocity of achievement appears to 
be related to longer life span in this population. The fact that the 
median age of achievement differs for deceased and still-living 
athletes in many cohorts (i.e., decade of entry and league) of 
athletes suggests that this trend may be systematic, not random, 
and that the Part 2 analyses are a more accurate reflection of 
achievement and mortality trends within this population. It also 
introduces the possibility of an additional bias; that the median 
age of achievement in previous studies of deceased-only samples 
may not accurately reflect the true median value for the entire 
population of eminent achievers. As Hanley and Foster (14), p. 
8 suggest, “Theories such as the just-cited precocity-longevity 
hypothesis are seductive, and have a certain plausibility. But some 
of this may be a result of the framing.” This seems to be the case for 
our data; as such, we conclude that the trends observed in Part 1 
appear to be less representative of achievement trends than those 
observed in Part 2.
There are many reasons that the P-L effect may not exist in 
the current sample of high achievers. As Lemez et al. (9) noted, 
there are notable differences between previous research and the 
current investigation that might explain these discrepancies. 
First, given the importance of physical fitness for the reduction 
of all-cause mortality (15), it is possible that the high levels of 
physical fitness required for elite performance in basketball play-
ers compared with the domains examined by McCann (1) and 
the baseball players examined by Abel and Kruger (7) buffered 
the effect of precocity on longevity. Moreover, beginning a 
professional career earlier and having the potential for longer 
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exposure to financial rewards, health care, and fitness-related 
health benefits may explain the finding that early achievers have 
longer life spans in this sample. A related explanation is that 
players who eventually make it to play professional basketball, 
regardless of their age of debut, have a superior genotype for 
physical fitness than those in other domains, which negates any 
relationship between early achievement and length of life span. 
The “Healthy Worker Effect” describes a form of selection bias 
wherein inclusion into a study sample reflects a health-advantage 
compared to those not included [see Rothman (16)]. As such, 
the Part 1 analyses of deceased-only athletes, which appear to 
support the trend for the P-L hypothesis, may reflect a sort of 
“inverse-healthy worker effect.”
Although the results of the current study add to a relatively 
limited evidence base regarding predictors of mortality in elite 
and professional sport, the current study did not provide any 
insights on cause-specific mortality. Nor can it be said at this 
point that the P-L hypothesis can be conclusively rejected. Future 
investigations would benefit from larger sample sizes, and from 
more nuanced categorizations of “age of achievement” (e.g., 
a three or four level categorical age of achievement variable 
rather than a dichotomized median split). It may also be useful 
to incorporate cause-specific mortality, and to explore disease 
links to sport participation, as well as any subsequent links to 
the proposed underlying mechanisms of the P-L effect, such as 
stress and personality. These areas may provide further insight 
into the long-term risks and benefits of participation in elite 
sport. The historical nature of this sample, and the possibility of 
generational differences in mortality trends and life expectancy, 
also reinforce the need to incorporate cause-specific mortality 
in future research. It will be important to consider these factors 
when exploring the generalizability of the current findings in 
other samples of eminent athletes.
In summary, the results of the current study suggest it is 
unlikely that the P-L effect exists in NBA athletes. Importantly, 
the current study also raises a methodological consideration 
regarding the estimates of average precocity values, and whether 
or not the average age of precocious achievement among 
deceased eminent achievers is an accurate reflection of the entire 
eminent population. An average age of achievement among still-
living eminent achievers that is significantly different than that 
of deceased eminent achievers could skew the results (as was 
likely the case for our data). Going forward, it will be important 
to consider how the physical demands of a sport, the health and 
financial benefits-associated with participation in high perfor-
mance sport, and measurement methodologies may influence 
support for the P-L hypothesis in sport. Given the significant 
dedication toward talent identification and development at 
early ages in many sports worldwide, the potential relationship 
between the milestones of athlete development and athlete 
health outcomes are important to consider.
aUThOr cOnTriBUTiOns
The authors NW, SL, CA, MR, and JB contributed equally to this 
work.
reFerences
1. McCann SJH. The precocity-longevity hypothesis: earlier peaks in career 
achievement predict shorter lives. Pers Soc Psychol Bull (2001) 27:1429–39. 
doi:10.1177/01461672012711004 
2. Taylor SE. Health Psychology. 4th ed. New York: McGraw-Hill (1999).
3. Sapolsky RM. Why Zebras Don’t Get Ulcers. 3rd ed. New York: Holt 
Paperbacks (2004).
4. McLeod SA. Type A Personality. (2011). Available from: http://www.simplyp-
sychology.org/personality-a.html
5. Friedman M, Rosenman RH. Association of specific overt behavior 
pattern with blood and cardiovascular findings blood cholesterol level, 
blood clotting time, incidence of arcus senilis, and clinical coronary artery 
disease. J Am Med Assoc (1959) 169:1286–96. doi:10.1001/jama.1959. 
03000290012005 
6. Myrtek M. Meta-analyses of prospective studies on coronary heart disease, 
type A personality, and hostility. Int J of Cardiol (2001) 79:245–51. doi:10.1016/
S0167-5273(01)00441-7 
7. Abel EL, Kruger ML. Precocity predicts shorter life for major league 
baseball players: confirmation of McCann’s precocity-longevity hypothesis. 
Death Stud (2007) 31:933–40. doi:10.1080/07481180701603428 
8. McCann SJH. Achievement age-death age correlations alone cannot provide 
unequivocal support for the precocity-longevity hypothesis. J Psychol (2004) 
138:293–302. doi:10.3200/JRLP.138.4.293-302 
9. Lemez S, Wattie N, Ardern CI, Baker J. The precocity-longevity hypothesis 
re-examined: does career start age in Canadian National Hockey League 
players influence length of lifespan? J Sports Sci Med (2014) 13:969–70. 
10. Simonton DK. Greatness: Who Makes History and Why? New York: The 
Guilford Press (1994).
11. Harriss DJ, Atkinson G. Ethical standards in sport and exercise science research: 
2014 update. Int J Sports Med (2013) 34:1015–28. doi:10.1055/s-0033-1358756
12. Shouler K, Ryan B, Smith S, Koppett L, Bellotti B. Total Basketball: The 
Ultimate Basketball Encyclopedia. Toronto: Sports Media Publishing (2003).
13. MVP Nash Highlights All-NBA First Team. (2006). Available from: http:// 
NBA.com
14. Hanley JA, Foster BJ. Avoiding blunders involving ‘immortal time’. Int 
J Epidemiol (2014) 43(3):949–61. doi:10.1093/ije/dyu105 
15. Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, 
Celermajer DS, et  al. Mortality of French participants in the Tour de 
France (1947-2012). Eur Heart J (2013) 34:3145–50. doi:10.1093/eurheartj/ 
eht347 
16. Rothman KJ. Biases in study design. Epidemiology: An Introduction. 
New York: Oxford University Press (2002). p. 94–112.
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Wattie, Lemez, Ardern, Rotondi and Baker. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, pro-
vided the original author(s) or licensor are credited and that the original publication 
in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms.
